Main Story
-
GREATER DES MOINES PARTNERSHIP NAMED 2026 CHAMBER OF THE YEAR BY ACCE
Recognition highlights Greater Des Moines as a national leader in regional collaboration, innovation GREATER DES MOINES, Iowa, July 22, 2026 /PRNewswire/ — The Greater Des Moines Partnership has been named the 2026 Chamber of the Year by the Association of Chamber of Commerce Executives (ACCE), earning the chamber profession’s highest honor for the first time…
Products
-
AccuSure AS9 Fully Automatic Digital Blood Pressure Monitor With Large Display
Original price was: ₹1,733.00.₹998.00Current price is: ₹998.00. -
AGEasy Max Group Fully Automatic One Touch Digital Blood Pressure Monitoring Device
Original price was: ₹1,405.00.₹949.00Current price is: ₹949.00. -
Automatic Digital Blood Pressure Monitor for Upper Arm, Large LCD Display
Original price was: ₹2,399.00.₹448.00Current price is: ₹448.00. -
Beurer German Engineering P0 13 Kid’s Pulse Oximeter I Fingertip Home Pulse Oximeter
Original price was: ₹2,745.00.₹1,538.00Current price is: ₹1,538.00. -
BPL Medical Technologies Bluetooth Enabled Arm Type Blood Pressure Monitor
Original price was: ₹6,563.00.₹5,199.00Current price is: ₹5,199.00.
Automobile
Tech
Entertainment
-
Dhamaal 4 Cast Brings Big-Screen Entertainment to Timezone, Creating Memorable Family Experiences
Mumbai, Maharashtra, India Reinforcing its status as a premier hub for family entertainment, Timezone India has announced a strategic partnership with T-Series for the upcoming release of Dhamaal 4. To mark the collaboration, Timezone’s Inorbit Malad venue recently played host to the film’s star cast—Ajay Devgn, Riteish Deshmukh, Ravi Kishan, and Anjali Anand. The event…
Health
-
Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma
July 22, 2026 02:00 ET | Source: Healx Cambridge, UK – 22 July, 2026 – Healx, an AI-powered, clinical-stage biotech company dedicated to rare diseases, today announced that the first patient has been dosed in its Phase 1/2 dose-escalation and dose-confirmation clinical trial to evaluate the safety and efficacy of HLX-4310, an investigational oral combination…
-
Apollo Hospitals Brings Next-Generation Lysin Science to India’s Fight Against AMR – Collaborates with Precisio Biotix
HYDERABAD, India, July 21, 2026 /PRNewswire/ — Apollo Hospitals today announced a strategic collaboration with Precisio Biotix to accelerate the development and clinical adoption of lysin-based antimicrobials in India – marking a significant step forward in combating antimicrobial resistance (AMR). This partnership will focus on translational research, clinical validation, and potential deployment pathways for lysin-based therapies across…
-
Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer
Seasoned executive leader and physician-scientist brings deep immunology and transplant medicine experience Company strengthens executive team as it advances its lead ex vivo donor-organ therapy ALG-115 toward clinical entry ALG-115 is designed to transform the treatment of graft rejection in lung transplantation Hanover, Germany, July 21, 2026 – Allogenetics today announced the appointment of Jeroen Rovers,…
-
Zydus Hospital, Ahmedabad’s Surgeons Reattach Toddler’s Severed Fingers in a 12-Hour Race Against Time
AHMEDABAD, India, July 21, 2026 /PRNewswire/ — Hand and limb trauma remains one of the most time-sensitive emergencies. Unlike many surgeries that allow for observation and planning, traumatic amputations and crush injuries operate on a strict biological clock as the tissues that are deprived of blood supply for too long cannot be saved. Correct handling…
-
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the Paul-Ehrlich-Institute (PEI), regarding the underlying biology and proposed non-clinical development plan for its most-advanced development program based on its proprietary…
-
Fostering new opportunities in the Greater Bay Area and Asia’s Pharmaceutical Industry
SHANGHAI, July 20, 2026 /PRNewswire/ — Following the landmark success of CPHI & PMEC China in June 2026, which welcomed an unprecedented gathering of industry professionals and fostered pivotal connections across the pharmaceutical supply chain, attention now shifts to South China. Building on this momentum, CPHI & PMEC Shenzhen 2026 will take place from 16-18…
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
